In The News
Stay informed with the latest research breakthroughs, treatment updates, and community stories related to Parkinson’s disease.
Original Investigation
Intermittent Theta-Burst Stimulation for Depressive Symptoms in Parkinson Disease A Randomized Clinical Trial JAMA Netw Open Published Online: May 20, 2026 2026;9;(5):e2613580. doi:10.1001/jamanetworkopen.2026.13580...
Gene therapy strategy may ease Parkinson’s disease dyskinesia
Mouse study targets GluN2B receptor subunit in movement-control neurons Written by Marisa Wexler, MS | June 8, 2026 Many people with Parkinson’s disease develop dyskinesia, or uncontrolled movements, after long-term levodopa treatment. In a mouse model,...
Can You Drive If You Have Parkinson’s?
Medically reviewed by Meredith Goodwin, MD, FAAFP — Written by The Healthline Editorial Team — Updated on June 16, 2025 Key takeaways Parkinson’s disease can impair driving ability due to its effects on vision, motor function, memory, and spatial awareness, though the...
5 common misconceptions about Parkinson’s disease
A Parkinson's journey is rarely straightforward and varies from patient to patient Written by Mary Beth Skylis | June 4, 2026 Before my dad’s Parkinson’s diagnosis in 2013, my understanding of the disease was limited. I knew someone from church who had it, mainly...
Keeping sharp: How to nourish cognitive health
Last updated Aug. 1, 2025, by Patricia Weiser, PharmD Fact-checked by Patrícia Silva, PhD Cognitive changes Tips Brain exercises Helpful tools Cognitive changes are a common part of living with Parkinson’s disease. These shifts in memory, attention, or decision-making...
Banning paraquat could be our Erin Brockovich moment for Parkinson’s
Multiple states are now considering legislation to ban the herbicide Written by Doc Irish | June 2, 2026 There are moments when a disease stops being only a medical story and becomes a public trust story. A prevention story. A question of whether the people who know...
Phase 2a trial of Jotrol for Parkinson’s begins enrolling patients in the U.S.
Experimental treatment's safety, tolerability will be assessed Written by Andrea Lobo | June 2, 2026 A Phase 2a trial of Jotrol is enrolling Parkinson's disease patients. Jotrol aims to reduce brain inflammation and oxidative stress. The trial will assess Jotrol's...
Parkinson’s-Linked Protein May Drive Faster Alzheimer’s Progression in Women
By Simon Spichak, MSc / Published On: May 11, 2026 “Originally published on Being Patient, an editorially independent news site covering the latest research on Alzheimer’s disease and brain health.” A new study finds that the protein alpha-synuclein may accelerate...
Reflecting on the many unexpected effects of being a Parkinson’s caregiver
Many caregivers experience a sense of loss for the person they were before Written by Jamie Askari | May 26, 2026 My husband, Arman, who has early-onset Parkinson’s disease, and I don’t get to the movies very often. Instead, we prefer to wait and stream films from the...
Blood test may help detect early Parkinson’s-related protein misfolding
iRS platform is being developed as a possible early detection tool Written by Andrea Lobo | May 28, 2026 German researchers developed an iRS blood test that may help support earlier Parkinson’s detection. The test is designed to identify misfolded alpha-synuclein, a...